Prenatal Exclusion of Alpha1-Antitrypsin Deficiency in a High-Risk Fetus
- 21 June 1979
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 300 (25) , 1441-1442
- https://doi.org/10.1056/nejm197906213002515
Abstract
To the Editor: One of the most common metabolic diseases,α1-antitrypsin deficiency, is associated mainly with cirrhosis in children and with chronic obstructive lung disease in adults.1 2 3 This antitrypsin is the major protease inhibitor (Pi) of human serum. We should like to report our first prenatal study for α1-antitrypsin deficiency in a fetus at high risk for this disease. The fetal blood was obtained by means of fetoscopy.With use of the electrofocusing technic, the microheterogenous patterns in serum of the normal Pi MM, the heterozygote Pi MZ and the deficient homozygote Pi ZZ phenotypes can be . . .Keywords
This publication has 8 references indexed in Scilit:
- Alpha1-Antitrypsin DeficiencyNew England Journal of Medicine, 1978
- Properties of Isolated Human alpha1-Antitrypsins of Pi Types M, S and ZEuropean Journal of Biochemistry, 1978
- TRANSVAGINAL APPROACH FOR SAMPLING OF FETAL BLOODThe Lancet, 1976
- α-1 Antitrypsin phenotypes determined by isoelectric focusing of the cysteine-antitrypsin mixed disulfide in serumAnalytical Biochemistry, 1976
- Liver Disease in Alpha1-Antitrypsin Deficiency Detected by Screening of 200,000 InfantsNew England Journal of Medicine, 1976
- The Current Status of α-1-Antitrypsin, a Protease Inhibitor, in Gastrointestinal DiseaseGastroenterology, 1976
- In Utero Diagnosis of HemoglobinopathiesNew England Journal of Medicine, 1974
- Amniotic fluid proteins: Maternal and fetal contributionsThe Journal of Pediatrics, 1974